Etoposide: all 654 studies that test it
Page 5 of 7. Open to participants first (83), then studies with results posted, then the rest; newest registration first within each.
- Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC)Status unknownNCT02179528Phase 2
- Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk NeuroblastomaActive, not recruitingNCT02176967Phase 3
- Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic LeukemiaActive, not recruitingNCT02153580Phase 1
- Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell LymphomaActive, not recruitingNCT02106988Phase 2
- Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable PatientsStatus unknownNCT02099188Phase 2
- Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable PatientsStatus unknownNCT02099175Phase 2
- Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AMLActive, not recruitingNCT02094794Phase 2
- Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT02070458Phase 1
- Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic LeukemiaCompletedNCT02036489Phase 4
- Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT02029950Phase 1
- Study of Sequential High-dose Chemotherapy in Children With High Risk MedulloblastomaTerminatedNCT02025881Phase 1/2
- Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT01904643Phase 1
- Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic MalignanciesCompletedNCT01900509Phase 1
- Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified ChemotherapyActive, not recruitingNCT01871766Phase 2
- Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12ACompletedNCT01858922Phase 2
- Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult MedulloblastomasStatus unknownNCT01857453Phase 2
- High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin LymphomaActive, not recruitingNCT01840566Phase 1
- Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaWithdrawnNCT01769911Not applicable
- Dose Adjusted EPOCH-R, to Treat Mature B Cell MalignanciesCompletedNCT01760226Early Phase 1
- ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic TumorsCompletedNCT01756989Phase 2
- Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant ChemotherapyCompletedNCT01710176Phase 3
- Lenalidomide Plus Chemotherapy for AMLCompletedNCT01681537Phase 1
- Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute LeukemiaWithdrawnNCT01677949Phase 2
- A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid MalignanciesSuspendedNCT01604863Phase 1
- Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell LymphomaCompletedNCT01590732Phase 1
- A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or TaxanesCompletedNCT01589159Phase 2
- Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)CompletedNCT01579929Phase 1
- Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer)TerminatedNCT01573338Phase 1/2
- Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung CancerTerminatedNCT01565772Phase 1
- Pilot Study of Etoposide-based Therapy and Hematopoietic Cell Transplantation for Hemophagocytic LymphohistiocytosisTerminatedNCT01547143Not applicable
- High Dose Chemotherapy and Autologous Transplant for NeuroblastomaCompletedNCT01526603Not applicable
- Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab EvaluationCompletedNCT01516567Phase 2
- Auto Transplant for High Risk or Relapsed Solid or CNS TumorsCompletedNCT01505569Not applicable
- Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchTerminatedNCT01500161Phase 2
- Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast CancerStatus unknownNCT01492556Phase 2
- Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell TumorsStatus unknownNCT01424839Phase 4
- Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic LeukaemiaStatus unknownNCT01423747Phase 3
- ALL-SCT BFM International- HSCT in Children and Adolescents With ALLStatus unknownNCT01423500Phase 3
- Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by SurgeryTerminatedNCT01411098Phase 1
- Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal MetastasisCompletedNCT01281696Phase 2
- Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid LeukemiaTerminatedNCT01260714Phase 1
- A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of ResponseTerminatedNCT01258634Phase 1
- Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's LymphomaCompletedNCT01251107Phase 3
- Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01249430Phase 1
- Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALLCompletedNCT01228331Phase 2/3
- Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung CancerWithdrawnNCT01160731Phase 1
- Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung CancerCompletedNCT01134861Phase 3
- Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01127009Phase 1
- International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic LeukemiaCompletedNCT01117441Phase 3
- Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT01085617
- BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)Status unknownNCT01063439Phase 2
- IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML)TerminatedNCT01027923Phase 1
- Merkel Positron Emission Tomography (PET) ProtocolCompletedNCT01013779Phase 2
- Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus TumorsCompletedNCT00984997Phase 2
- Carboplatin-Etoposide Combination in Hormone-Resistant Prostate CancersCompletedNCT00973882Phase 2
- Infusion of Expanded Cord Blood T CellsWithdrawnNCT00972101Phase 1
- Carboplatin and Etoposide Plus LBH589 for Small Cell Lung CancerTerminatedNCT00958022Phase 1
- A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung CancerCompletedNCT00927875Phase 1
- A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced CancersCompletedNCT00926640Phase 1
- Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin LymphomaStatus unknownNCT00908180Phase 2
- Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute LeukemiasTerminatedNCT00882076Phase 1
- Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid TumorsCompletedNCT00881166Phase 1
- Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue SarcomaCompletedNCT00876031Phase 3
- Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior TherapyActive, not recruitingNCT00871013Phase 2
- MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00869752Phase 1/2
- UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionActive, not recruitingNCT00869232Phase 2
- Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad PrognosisCompletedNCT00864318Phase 2
- Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to TreatmentWithdrawnNCT00829205Phase 1/2
- A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid TumorsTerminatedNCT00811993Phase 1
- Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid TumorsTerminatedNCT00807755Phase 1
- Denileukine Diftitox for Relapsed ALCLWithdrawnNCT00801918Phase 2
- Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk NeuroblastomaCompletedNCT00793845Phase 2
- A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.CompletedNCT00776698Phase 1
- Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic LeukemiaStatus unknownNCT00764907Phase 3
- Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in ChildrenCompletedNCT00749723Phase 2/3
- Autologous Stem Cell Transplant for Neurologic Autoimmune DiseasesActive, not recruitingNCT00716066Phase 2
- Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic MalignanciesCompletedNCT00697671Phase 1
- Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT00682383Phase 2
- Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin LymphomaCompletedNCT00678327Phase 3
- Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid LeukemiaTerminatedNCT00660036Phase 1
- Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung CancerCompletedNCT00658580Phase 3
- Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated LymphomaCompletedNCT00641381Phase 1
- Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00627354Phase 2
- MT2004-30: Tomotherapy for Solid TumorsTerminatedNCT00623077Phase 1
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryStatus unknownNCT00616785Phase 2
- Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic LeukemiaCompletedNCT00613457Phase 3
- Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant GliomasCompletedNCT00613223Phase 1
- Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid TumorsCompletedNCT00573690Phase 1
- Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related LymphomaCompletedNCT00569985Phase 1
- Etoposide and Celecoxib in Patients With Advanced CancerCompletedNCT00551005Phase 1
- R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung CancerCompletedNCT00544596Phase 1
- STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing StudyStatus unknownNCT00526396Phase 3
- A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell TransplantTerminatedNCT00515138Early Phase 1
- Valproate and Etoposide for Patients With Neuronal Tumors and Brain MetastasesCompletedNCT00513162Phase 1
- Recombinant Interferon Alpha and Etoposide in Relapsed OsteosarcomaCompletedNCT00504140Phase 2
- Velcade Plus ICE for Patients With Relapsed Classical Hodgkin LymphomaCompletedNCT00439361Phase 1
- Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic LeukemiaCompletedNCT00430118Phase 3
- Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004CompletedNCT00426101Phase 3
- Combination Chemotherapy in Treating Young Male Patients With Hodgkin's LymphomaCompletedNCT00398554Phase 2
- Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain TumorsStatus unknownNCT00392886Phase 3